469 related articles for article (PubMed ID: 28465426)
1. A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue Viruses.
Pryke KM; Abraham J; Sali TM; Gall BJ; Archer I; Liu A; Bambina S; Baird J; Gough M; Chakhtoura M; Haddad EK; Kirby IT; Nilsen A; Streblow DN; Hirsch AJ; Smith JL; DeFilippis VR
mBio; 2017 May; 8(3):. PubMed ID: 28465426
[TBL] [Abstract][Full Text] [Related]
2. Emerging Alphaviruses Are Sensitive to Cellular States Induced by a Novel Small-Molecule Agonist of the STING Pathway.
Gall B; Pryke K; Abraham J; Mizuno N; Botto S; Sali TM; Broeckel R; Haese N; Nilsen A; Placzek A; Morrison T; Heise M; Streblow D; DeFilippis V
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263267
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of dengue and chikungunya virus infections by RIG-I-mediated type I interferon-independent stimulation of the innate antiviral response.
Olagnier D; Scholte FE; Chiang C; Albulescu IC; Nichols C; He Z; Lin R; Snijder EJ; van Hemert MJ; Hiscott J
J Virol; 2014 Apr; 88(8):4180-94. PubMed ID: 24478443
[TBL] [Abstract][Full Text] [Related]
4. Integrated human-virus metabolic stoichiometric modelling predicts host-based antiviral targets against Chikungunya, Dengue and Zika viruses.
Aller S; Scott A; Sarkar-Tyson M; Soyer OS
J R Soc Interface; 2018 Sep; 15(146):. PubMed ID: 30209043
[TBL] [Abstract][Full Text] [Related]
5. Targeting Innate Immunity for Antiviral Therapy through Small Molecule Agonists of the RLR Pathway.
Pattabhi S; Wilkins CR; Dong R; Knoll ML; Posakony J; Kaiser S; Mire CE; Wang ML; Ireton RC; Geisbert TW; Bedard KM; Iadonato SP; Loo YM; Gale M
J Virol; 2015 Dec; 90(5):2372-87. PubMed ID: 26676770
[TBL] [Abstract][Full Text] [Related]
6. A MicroRNA Screen Identifies the Wnt Signaling Pathway as a Regulator of the Interferon Response during Flavivirus Infection.
Smith JL; Jeng S; McWeeney SK; Hirsch AJ
J Virol; 2017 Apr; 91(8):. PubMed ID: 28148804
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the antiviral activity of orlistat (tetrahydrolipstatin) against dengue virus, Japanese encephalitis virus, Zika virus and chikungunya virus.
Hitakarun A; Khongwichit S; Wikan N; Roytrakul S; Yoksan S; Rajakam S; Davidson AD; Smith DR
Sci Rep; 2020 Jan; 10(1):1499. PubMed ID: 32001767
[TBL] [Abstract][Full Text] [Related]
8. Dengue Virus Subverts Host Innate Immunity by Targeting Adaptor Protein MAVS.
He Z; Zhu X; Wen W; Yuan J; Hu Y; Chen J; An S; Dong X; Lin C; Yu J; Wu J; Yang Y; Cai J; Li J; Li M
J Virol; 2016 Aug; 90(16):7219-7230. PubMed ID: 27252539
[TBL] [Abstract][Full Text] [Related]
9. Seneca Valley Virus Suppresses Host Type I Interferon Production by Targeting Adaptor Proteins MAVS, TRIF, and TANK for Cleavage.
Qian S; Fan W; Liu T; Wu M; Zhang H; Cui X; Zhou Y; Hu J; Wei S; Chen H; Li X; Qian P
J Virol; 2017 Aug; 91(16):. PubMed ID: 28566380
[TBL] [Abstract][Full Text] [Related]
10. Comparative Analysis of African and Asian Lineage-Derived Zika Virus Strains Reveals Differences in Activation of and Sensitivity to Antiviral Innate Immunity.
Esser-Nobis K; Aarreberg LD; Roby JA; Fairgrieve MR; Green R; Gale M
J Virol; 2019 Jul; 93(13):. PubMed ID: 31019057
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a Novel Human-Specific STING Agonist that Elicits Antiviral Activity Against Emerging Alphaviruses.
Sali TM; Pryke KM; Abraham J; Liu A; Archer I; Broeckel R; Staverosky JA; Smith JL; Al-Shammari A; Amsler L; Sheridan K; Nilsen A; Streblow DN; DeFilippis VR
PLoS Pathog; 2015 Dec; 11(12):e1005324. PubMed ID: 26646986
[TBL] [Abstract][Full Text] [Related]
12. Human Cytomegalovirus DNA Polymerase Subunit UL44 Antagonizes Antiviral Immune Responses by Suppressing IRF3- and NF-κB-Mediated Transcription.
Fu YZ; Su S; Zou HM; Guo Y; Wang SY; Li S; Luo MH; Wang YY
J Virol; 2019 Jun; 93(11):. PubMed ID: 30867312
[TBL] [Abstract][Full Text] [Related]
13. Dengue Virus NS Proteins Inhibit RIG-I/MAVS Signaling by Blocking TBK1/IRF3 Phosphorylation: Dengue Virus Serotype 1 NS4A Is a Unique Interferon-Regulating Virulence Determinant.
Dalrymple NA; Cimica V; Mackow ER
mBio; 2015 May; 6(3):e00553-15. PubMed ID: 25968648
[TBL] [Abstract][Full Text] [Related]
14. Sophoraflavenone G Restricts Dengue and Zika Virus Infection via RNA Polymerase Interference.
Sze A; Olagnier D; Hadj SB; Han X; Tian XH; Xu HT; Yang L; Shi Q; Wang P; Wainberg MA; Wu JH; Lin R
Viruses; 2017 Oct; 9(10):. PubMed ID: 28972551
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C Virus Infection Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4A.
Vazquez C; Tan CY; Horner SM
J Virol; 2019 Dec; 93(23):. PubMed ID: 31534039
[TBL] [Abstract][Full Text] [Related]
16. Viral priming of cell intrinsic innate antiviral signaling by the unfolded protein response.
Carletti T; Zakaria MK; Faoro V; Reale L; Kazungu Y; Licastro D; Marcello A
Nat Commun; 2019 Aug; 10(1):3889. PubMed ID: 31467282
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways.
Han L; Zhuang MW; Deng J; Zheng Y; Zhang J; Nan ML; Zhang XJ; Gao C; Wang PH
J Med Virol; 2021 Sep; 93(9):5376-5389. PubMed ID: 33913550
[TBL] [Abstract][Full Text] [Related]
18. How Dengue Virus Circumvents Innate Immunity.
Kao YT; Lai MMC; Yu CY
Front Immunol; 2018; 9():2860. PubMed ID: 30564245
[TBL] [Abstract][Full Text] [Related]
19. Viral Protein Accumulation of Zika Virus Variants Links with Regulation of Innate Immunity for Differential Control of Viral Replication, Spread, and Response to Interferon.
Lu AY; Gustin A; Newhouse D; Gale M
J Virol; 2023 May; 97(5):e0198222. PubMed ID: 37162358
[TBL] [Abstract][Full Text] [Related]
20. Betulinic acid exhibits antiviral effects against dengue virus infection.
Loe MWC; Hao E; Chen M; Li C; Lee RCH; Zhu IXY; Teo ZY; Chin WX; Hou X; Deng J; Chu JJH
Antiviral Res; 2020 Dec; 184():104954. PubMed ID: 33080251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
